Essential oils in the treatment of respiratory tract diseases highlighting their role in bacterial infections and their anti‐inflammatory action: a review
Identifieur interne : 000E36 ( Main/Exploration ); précédent : 000E35; suivant : 000E37Essential oils in the treatment of respiratory tract diseases highlighting their role in bacterial infections and their anti‐inflammatory action: a review
Auteurs : Györgyi Horváth [Hongrie] ; Kamilla Ács [Hongrie]Source :
- Flavour and Fragrance Journal [ 0882-5734 ] ; 2015-09.
Abstract
The appearance of multidrug resistant bacteria and growing antibiotic resistance is leading to a continuous need for discovering new drugs and alternative treatments against infections. The investigation of the antibacterial effect of essential oils (EOs), which are commonly used nowadays in cosmetics, health care, traditional medicine and food industry, could be one of the promising solutions for this worldwide problem. EOs have a complex mode of action due to their multiple composition. Respiratory tract diseases (RTDs) associated with bacterial infection and inflammation affect a large number of people from every age group worldwide. Because of volatility, EOs can easily reach the upper and lower parts of the respiratory tract via inhalation. Moreover, due to their antimicrobial and anti‐inflammatory potency, they offer an effective treatment in respiratory tract infections (RTIs). The purpose of this review is to describe the most frequently developing infections of the upper and lower respiratory tract and to show methods used for the determination of the antibacterial activity of EOs by gaseous contact. The mode of action of EOs on bacterial cells and their anti‐inflammatory action are also discussed. Results coming from recently performed in vivo animal studies as well as human trials are also reported. Patents deal with the role of EOs and their volatile constituents in the treatment of RTIs are also introduced. On the whole, this review aimed at showing EOs as potential antimicrobials and as anti‐inflammatory agents to alleviate symptoms and signs of RTDs including RTIs. Copyright © 2015 John Wiley & Sons, Ltd.
This review focuses on a description of the most frequently developing infections in the respiratory tract and demonstration of the antibacterial activity of EOs in vapour‐phase. The effect of EOs on bacterial cells and their anti‐inflammatory action are also discussed. Results of in vivo animal studies as well as human trials are also reported. Patents deal with the role of EOs and their volatile constituents in the treatment of respiratory tract infections are also introduced.
Url:
DOI: 10.1002/ffj.3252
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001067
- to stream Istex, to step Curation: 001029
- to stream Istex, to step Checkpoint: 000156
- to stream Main, to step Merge: 000E37
- to stream Main, to step Curation: 000E36
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Essential oils in the treatment of respiratory tract diseases highlighting their role in bacterial infections and their anti‐inflammatory action: a review</title><author><name sortKey="Horvath, Gyorgyi" sort="Horvath, Gyorgyi" uniqKey="Horvath G" first="Györgyi" last="Horváth">Györgyi Horváth</name></author><author><name sortKey="Acs, Kamilla" sort="Acs, Kamilla" uniqKey="Acs K" first="Kamilla" last="Ács">Kamilla Ács</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:D6F629E29DDB1C7AE136F2F6F6B4848A5771FBF7</idno><date when="2015" year="2015">2015</date><idno type="doi">10.1002/ffj.3252</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-SJ5SVZVJ-T/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001067</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001067</idno><idno type="wicri:Area/Istex/Curation">001029</idno><idno type="wicri:Area/Istex/Checkpoint">000156</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000156</idno><idno type="wicri:doubleKey">0882-5734:2015:Horvath G:essential:oils:in</idno><idno type="wicri:Area/Main/Merge">000E37</idno><idno type="wicri:Area/Main/Curation">000E36</idno><idno type="wicri:Area/Main/Exploration">000E36</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Essential oils in the treatment of respiratory tract diseases highlighting their role in bacterial infections and their anti‐inflammatory action: a review</title><author><name sortKey="Horvath, Gyorgyi" sort="Horvath, Gyorgyi" uniqKey="Horvath G" first="Györgyi" last="Horváth">Györgyi Horváth</name><affiliation wicri:level="1"><country xml:lang="fr">Hongrie</country><wicri:regionArea>Department of Pharmacognosy, University of Pécs, Rókus street 2, 7624, Pécs</wicri:regionArea><wicri:noRegion>Pécs</wicri:noRegion></affiliation><affiliation wicri:level="1"><country wicri:rule="url">Hongrie</country></affiliation></author><author><name sortKey="Acs, Kamilla" sort="Acs, Kamilla" uniqKey="Acs K" first="Kamilla" last="Ács">Kamilla Ács</name><affiliation wicri:level="1"><country xml:lang="fr">Hongrie</country><wicri:regionArea>Department of Pharmacognosy, University of Pécs, Rókus street 2, 7624, Pécs</wicri:regionArea><wicri:noRegion>Pécs</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Flavour and Fragrance Journal</title><title level="j" type="alt">FLAVOUR AND FRAGRANCE JOURNAL</title><idno type="ISSN">0882-5734</idno><idno type="eISSN">1099-1026</idno><imprint><biblScope unit="vol">30</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="331">331</biblScope><biblScope unit="page" to="341">341</biblScope><biblScope unit="page-count">11</biblScope><date type="published" when="2015-09">2015-09</date></imprint><idno type="ISSN">0882-5734</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0882-5734</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract">The appearance of multidrug resistant bacteria and growing antibiotic resistance is leading to a continuous need for discovering new drugs and alternative treatments against infections. The investigation of the antibacterial effect of essential oils (EOs), which are commonly used nowadays in cosmetics, health care, traditional medicine and food industry, could be one of the promising solutions for this worldwide problem. EOs have a complex mode of action due to their multiple composition. Respiratory tract diseases (RTDs) associated with bacterial infection and inflammation affect a large number of people from every age group worldwide. Because of volatility, EOs can easily reach the upper and lower parts of the respiratory tract via inhalation. Moreover, due to their antimicrobial and anti‐inflammatory potency, they offer an effective treatment in respiratory tract infections (RTIs). The purpose of this review is to describe the most frequently developing infections of the upper and lower respiratory tract and to show methods used for the determination of the antibacterial activity of EOs by gaseous contact. The mode of action of EOs on bacterial cells and their anti‐inflammatory action are also discussed. Results coming from recently performed in vivo animal studies as well as human trials are also reported. Patents deal with the role of EOs and their volatile constituents in the treatment of RTIs are also introduced. On the whole, this review aimed at showing EOs as potential antimicrobials and as anti‐inflammatory agents to alleviate symptoms and signs of RTDs including RTIs. Copyright © 2015 John Wiley & Sons, Ltd.</div><div type="abstract">This review focuses on a description of the most frequently developing infections in the respiratory tract and demonstration of the antibacterial activity of EOs in vapour‐phase. The effect of EOs on bacterial cells and their anti‐inflammatory action are also discussed. Results of in vivo animal studies as well as human trials are also reported. Patents deal with the role of EOs and their volatile constituents in the treatment of respiratory tract infections are also introduced.</div></front></TEI><affiliations><list><country><li>Hongrie</li></country></list><tree><country name="Hongrie"><noRegion><name sortKey="Horvath, Gyorgyi" sort="Horvath, Gyorgyi" uniqKey="Horvath G" first="Györgyi" last="Horváth">Györgyi Horváth</name></noRegion><name sortKey="Acs, Kamilla" sort="Acs, Kamilla" uniqKey="Acs K" first="Kamilla" last="Ács">Kamilla Ács</name><name sortKey="Horvath, Gyorgyi" sort="Horvath, Gyorgyi" uniqKey="Horvath G" first="Györgyi" last="Horváth">Györgyi Horváth</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E36 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000E36 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= StressCovidV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:D6F629E29DDB1C7AE136F2F6F6B4848A5771FBF7
|texte= Essential oils in the treatment of respiratory tract diseases highlighting their role in bacterial infections and their anti‐inflammatory action: a review
}}
| This area was generated with Dilib version V0.6.33. |  |